BioSpace News Archive

The V Foundation for Cancer Research, a top-rated cancer research charity, announces $10.3 million in grant funding for 2020.

Calgary, Alberta--(Newsfile Corp. - January 28, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to announce that all follow-up visits of the subjects enrolled in the HS 12 -01 clinical trial will be completed by March 31, 2021.

Based on input from an independent expert, Institute for Supply Management® recently announced the completion of its annual adjustments to the seasonal factors used in the monthly Institute for Supply Management® Manufacturing PMI® Report On Business® and the monthly Services PMI® Report On Business®.

MicroGEM, a Virginia-based molecular diagnostics company, today announced its acquisition of Jump Start Manufacturing LLC (Jump Start), a New Hampshire-based engineering company with proven success in the biotech and pharmaceutical industry.

Evelo Biosciences, Inc., a clinical stage biotechnology company developing a new modality of orally delivered medicines, announced the pricing of an underwritten public offering of 4,500,000 shares of its common stock, at a public offering price of $15.00 per share, before underwriting discounts and commissions.

Novotech Health Holdings, the largest biotech specialist contract research organization in Asia, announced the appointment of Andy Liu as Head of China.

Lattice Biologics Ltd. announces financial results for Q4 2020 and year end 2020.

CTI BioPharma Corp. announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees with a grant date of January 28, 2021, as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

Molluscum contagiosum is a skin infection caused by a poxvirus (molluscum contagiosum virus), which is usually benign. Appearance of lesions anywhere on the body is a characteristic of mild skin disease.

Outsourcing is emerging as a cost-effective tool for healthcare payers. Therefore, the growing trend of outsourcing is working in favor of the global healthcare payer services market.